Mirum Pharmaceuticals, Inc. (MIRM)
NASDAQ·Healthcare·Biotechnology
$98.37
-2.23%
Mkt Cap $6.15B
Analyst Ratings
Buy
17
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
Implied Upside
+48.4%
Consensus $146.00 vs current $98.37
NASDAQ·Healthcare·Biotechnology
$98.37
-2.23%
Mkt Cap $6.15B
Buy
17
Hold
0
Sell
0
Price Target (49 analysts)
$146.00
Range $118.00 – $185.00
+48.4%
Consensus $146.00 vs current $98.37